HEAD OF THERAPEUTIC DISCOVERY
Zach Sweeney leads the Therapeutic Discovery group at Denali. Previously, he was a Director of Global Discovery Chemistry and Head of Analytical Chemistry at Novartis Emeryville. Zach also worked as a scientist at Genentech and Roche. His project teams have contributed to the identification of clinical candidates for the treatment of Parkinson's disease, inflammatory disorders, and infectious disease. Zach's teams have also authored over 40 patent applications and 30 scientific articles. He graduated with a degree in chemistry from Stanford University, received a Ph.D. from the University of California, Berkeley, and completed a postdoctoral fellowship at Harvard University.